Highlights: The Bitcoin price has already regained the lost levels above $91,000, with its daily trading volume up by 183%. Outflows from U.S. BTC Highlights: The Bitcoin price has already regained the lost levels above $91,000, with its daily trading volume up by 183%. Outflows from U.S. BTC

Bitcoin Price Eyes $94000 Mark as Key Support Holds and Momentum Shifts

Highlights:

  • The Bitcoin price has already regained the lost levels above $91,000, with its daily trading volume up by 183%.
  • Outflows from U.S. BTC ETFs totalled approximately $680 million over the last week, indicating a decline in demand.
  • The technical outlook indicates that the Bitcoin price eyes $94000, provided that the 50-day SMA (89,597) holds.

Bitcoin price (BTC) has reclaimed the $91,000 mark and remains above the 50-day Simple Moving Average (SMA) at $89,592. Meanwhile, weak institutional demand is indicated by a persistent outflow from U.S. spot Bitcoin Exchange-Traded Funds (ETFs), which may depress market sentiment. The derivatives market, by contrast, exhibits a selling bias, with more short positions.

Bitcoin remains at risk amid geopolitical tensions between the US and other nations, including Venezuela and Greenland. Moreover, the US Supreme Court’s next decision on tariffs will be announced on Wednesday, as U.S. President Donald Trump has called for a 10% reduction in credit card rates by January 20.

The flow of BTC ETFs is a sign of the weakened institutional support. According to Sosovalue, Bitcoin spot ETFs recorded an outflow of $681.01 million over the past week, with four consecutive days of outflows. 

Total Bitcoin Spot ETF Net Inflow: SoSoValue

On the other hand, the derivatives side shows capital inflows into Bitcoin futures, indicating a decrease in demand. According to CoinGlass data, BTC futures Open Interest (OI) has increased by 0.61% over the past 24 hours, reaching $61.58 billion. This indicates a slight decline in investor demand, as capital is exiting the market.

BTC Derivatives Data: CoinGlass

The long-to-short 24-hour ratio is at 0.9798, which implies that there are fewer active long positions. However, the volume rose 201% to $70.97 billion, indicating intense market activity, as the Bitcoin price eyes $94000 immediate resistance level.

Bitcoin Price Eyes $94000 Rebound

On the BTC/USD 1-day price chart, Bitcoin is holding above the key support level at $89,597. This support zone lies near recent lows and is closely monitored by traders.

If Bitcoin price falls below this area, the next major support is at $87,287- $84,184, as indicated by prior consolidation on the chart. The 50-day Simple Moving Average (SMA) is at $89,597, while the 200-day SMA is at $106,179.  The 200-day SMA, located well below the price, serves as a longer-term buffer against further upside.

BTC/USD 1-day chart: TradingView

Technical indicators indicate that Bitcoin is cooling off after the recent surge that saw it reach $94,200 on January 5. The Relative Strength Index (RSI) is at 55.00, meaning the coin is neither overbought nor oversold, which could signal room for more consolidation before the next large move. The MACD indicator has, however, flipped positive, indicating rising momentum and a possible risk of further upside.

If Bitcoin stays above the $89,597 support and buyers step in, the Bitcoin price could eye $94,000 rebound and even higher resistance near $100,000 in the next few weeks. However, if sellers push below the immediate support aligned with the 50-day SMA, Bitcoin may retest deeper supports around $87,000- $84,184 before bulls return.

eToro Platform

Best Crypto Exchange

  • Over 90 top cryptos to trade
  • Regulated by top-tier entities
  • User-friendly trading app
  • 30+ million users
9.9
Visit eToro

eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong.

Market Opportunity
Union Logo
Union Price(U)
$0.002858
$0.002858$0.002858
-1.10%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23